Although proteasome inhibitors effectively deplete autoreactive plasma cells and proved to be therapeutically effective in preclinical mouse models of LN, there is compelling evidence suggesting that immunoproteasome inhibition might selectively induces apoptosis in CD14 + monocytes, leading to suppression of IL-23-driven autoimmunity [52]. Here, CD14 is linked to Autoimmunity.